Chemistry: analytical and immunological testing – Peptide – protein or amino acid
Reexamination Certificate
2007-08-03
2009-06-23
Wallenhorst, Maureen M (Department: 1797)
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
C436S063000, C600S300000, C128S898000
Reexamination Certificate
active
07550299
ABSTRACT:
A method for predicting onset or risk of atrial fibrillation in a subject includes determining the presence of an oxidative stress marker, such as glutathione, cysteine, and/or a derivative of a reactive oxidative metabolite (DROM).
REFERENCES:
patent: 2005/0112572 (2005-05-01), Pincemail et al.
patent: 2005/0202521 (2005-09-01), Crum
patent: 2005/016216 (2005-02-01), None
Kim, Young Hoon et al. Gene Expression Profiling of Oxidative Stress on Atrial Fibrillation in Humans. Experimental and Molecular Medicine, vol. 35, No. 5, pp. 336-349, Oct. 2003.
Abramson, J. L.; Hooper, W. C.; Jones, D. P.; Ashfaq, S.; Rhodes, S. D.; Weintraub, W. S.; Harrison, D. G.; Quyyumi, A. A.; Vaccarino, V. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease.Atherosclerosis178:115-121; 2005.
Amar, D.; Zhang, H.; Heerdt, P. M.; Park, B.; Fleisher, M.; Thaler. H. T. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein.Chest128:3421-3427; 2005.
Aviles, R. J.; Martin, D. O.; Apperson-Hansen, C.; Houghtaling, P. L.; Rautaharju, P.; Kronmal, R. A.; Tracy, R. P.; Van Wagoner, D. R.; Psaty, B. M.; Lauer, M. S.; Chung, M. K. Inflammation as a risk factor for atrial fibrillation.Circulation108:3006-3010; 2003.
Barrington, P. L.; Martin, R. L.; Zhang, K. Slowly inactivating sodium currents are reduced by exposure to oxidative stress.J Mol Cell Cardiol29:3251-3265; 1997.
Benjamin, E. J.; Levy, D.; Vaziri, S. M.; D'Agostino, R. B.; Belanger, A. J.; Wolf, P. A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.JAMA271:840-844; 1994.
Boos, C. J.; Anderson, R. A.; Lip, G. Y. Is atrial fibrillation an inflammatory disorder?Eur Heart J27:136-149; 2006.
Braunwald, E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.N Engl J Med337:1360-1369; 1997.
Bruins, P.; te, V. H.; Yazdanbakhsh, A. P.; Jansen, P. G.; van Hardevelt, F. W.; de Beaumont, E. M.; Wildevuur, C. R.; Eijsman, L.; Trouwborst, A.; Hack, C. E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.Circulation96:3542-3548; 1997.
Cai, H.; Li, Z.; Goette, A.; Mera, F.; Honeycutt, C.; Feterik, K.; Wilcox, J. N.; Dudley, S. C., Jr.; Harrison, D. G.; Langberg, J. J. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke.Circulation106:2854-2858; 2002.
Calo, L.; Bianconi, L.; Colivicchi, F.; Lamberti, F.; Loricchio, M. L.; de Ruvo, E.; Meo, A.; Pandozi, C.; Staibano, M.; Santini, M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.J Am Coll Cardiol45:1723-1728; 2005.
Carnes, C. A.; Chung, M. K.; Nakayama, T.; Nakayama, H.; Baliga, R. S.; Piao, S.; Kanderian, A.; Pavia, S.; Hamlin, R. L.; McCarthy, P. M.; Bauer, J. A.; Van Wagoner, D. R. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation.Circ Res89:E32-E38; 2001.
Cesarone, M. R.; Belcaro, G.; Carratelli, M.; Cornelli, U.; De Sanctis, M. T.; Incandela, L.; Barsotti, A.; Terranova, R.; Nicolaides, A. A simple test to monitor oxidative stress.Int Angiol18:127-130; 1999.
Choudhary, G.; Dudley, S. C., Jr. Heart failure, oxidative stress, and ion channel modulation.Congest Heart Fail8:148-155; 2002.
Christ, M.; Bauersachs, J.; Liebetrau, C.; Heck, M.; Gunther, A.; Wehling, M. Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin.Diabetes51:2648-2652: 2002.
Chung, M. K.; Martin, D. O.; Sprecher, D.; Wazni, O.; Kanderian, A.; Carnes, C. A.; Bauer, J. A.; Tchou, P. J.; Niebauer, M. J.; Natale, A.; Van Wagoner, D. R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.Circulation104:2886-2891: 2001.
Ciaroni, S.; Cuenoud, L.; Bloch, A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension.Am Heart J139:814-819; 2000.
Conway, D. S.; Buggins, P.; Hughes, E.; Lip, G. Y. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.J Am Coll Cardiol43:2075-2085; 2004.
Cornelli, U.; Terranova, R.; Luca, S.; Cornelli, M.; Alberti, A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress.J Nutr131:3208-3211; 2001.
De Vecchi, E.; Pala, M. G.; Di Credico, G.; Agape, V.; Paolini, G.; Bonini, P. A.; Grossi, A.; Paroni, R. Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery.Heart79:242-247; 1998.
Dernellis, J.; Panaretou, M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation.Acta Cardiol56:375-380; 2001.
Dernellis, J.; Panaretou, M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.Eur Heart J25:1100-1107; 2004.
Dernellis, J.; Panaretou, M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation.Am Heart J150:1064; 2005.
Dudley, S. C., Jr.; Diamandopoulus, L.; Dikalov, S.; Fink, B.; Fink, N.; McCann, L.; Honeycutt, C.; Mera, F.; Harrison, D. G.; Langberg, J. J. Atrial fibrillation causes increased oxidative stress and decreased nitric oxide bioavailability in the left atrial appendage. Circulation 108:IV-147-IV-148. (2003).
Dudley, S. C., Jr.; Hoch, N. E.; McCann, L. A.; Honeycutt, C.; Diamandopoulus, L.; Fukai, T.; Harrison, D. G.; Langberg, J. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases.Circulation112:1266-1273; 2005.
Durak, I.; Elgun, S.; Kemal, B. N.; Burak Cimen, M. Y.; Kacmaz, M.; Buyukkocak, S.; Serdar, O. H. Effects of cigarette smoking with different tar content on erythrocyte oxidant/antioxidant status.Addiction Biology7:255-258; 2002.
Falk, R. H. Impacts of prospective peer review on pacemaker implantation rates in Massachusetts.J Am Coll Cardiol15:1087-1092; 1990.
Feinberg, W. M.; Blackshear, J. L.; Laupacis, A.; Kronmal, R.; Hart, R. G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.Arch Intern Med155:469-473; 1995.
Fontes, M. L.; Mathew, J. P.; Rinder, H. M.; Zelterman, D.; Smith, B. R.; Rinder, C. S. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation.Anesth Analg101:17-23, table; 2005.
Frustaci, A.; Chimenti, C.; Bellocci, F.; Morgante, E.; Russo, M. A.; Maseri, A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation.Circulation96:1180-1184; 1997.
Fukuda, K.; Davies, S. S.; Nakajima, T.; Ong, B. H.; Kupershmidt, S.; Fessel, J.; Amarnath, V.; Anderson, M. E.; Boyden, P. A.; Viswanathan, P. C.; Roberts, L. J.; Balser, J. R. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels.Circ Res97:1262-1269; 2005.
Furberg, C. D.; Psaty, B. M.; Manolio, T. A.; Gardin, J. M.; Smith, V. E.; Rautaharju, P. M. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).Am J Cardiol74:236-241; 1994.
Ganter, U.; Arcone, R.; Toniatti, C.; Morrone, G.; Ciliberto, G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6.EMBO J8:3773-3779; 1989.
Gaudino, M.; Andreotti, F.; Zamparelli, R.; Di Castelnuovo, A.; Nasso, G.; Burzotta, F.; lacoviello, L.; Donati, M.
Dudley, Jr. Samuel C.
Jones Dean P.
Agarwal, P.C. Dinesh
Emory University
The United States of America as represented by the Department of
Wallenhorst Maureen M
LandOfFree
Method for predicting onset/risk of atrial fibrillation (AF) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for predicting onset/risk of atrial fibrillation (AF), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting onset/risk of atrial fibrillation (AF) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4115657